These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 21163865

  • 1. Genetic variation in the renin--angiotensin system, use of renin--angiotensin system inhibitors and the risk of myocardial infarction.
    Maitland-van der Zee AH, van Wieren-de Wijer DB, de Boer A, Kroon AA, de Leeuw PW, Schiffers P, Janssen RG, Psaty BM, van Duijn CM, Stricker BH, Klungel OH.
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):208-14. PubMed ID: 21163865
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, Knol MJ, de Boer A, Grobbee DE, Geerlings MI, Heerdink ER, Klungel OH.
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genotypic interactions of renin-angiotensin system genes in myocardial infarction.
    Araújo MA, Goulart LR, Cordeiro ER, Gatti RR, Menezes BS, Lourenço C, Silva HD.
    Int J Cardiol; 2005 Aug 03; 103(1):27-32. PubMed ID: 16061119
    [Abstract] [Full Text] [Related]

  • 9. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.
    Franco E, Palumbo L, Crobu F, Anselmino M, Frea S, Matullo G, Piazza A, Trevi GP, Bergerone S.
    BMC Med Genet; 2007 May 22; 8():27. PubMed ID: 17519002
    [Abstract] [Full Text] [Related]

  • 10. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
    Smilde TD, Zuurman MW, Hillege HL, van Veldhuisen DJ, van Gilst WH, van der Steege G, Voors AA, Kors JA, de Jong PE, Navis G.
    Am J Hypertens; 2007 Oct 22; 20(10):1097-103. PubMed ID: 17903694
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic effect of angiotensin II type-1 receptor 1166A/C with angiotensin-converting enzyme polymorphism on risk of acute myocardial infarction in north Indians.
    Kaur R, Das R, Ahluwalia J, Kumar RM, Talwar KK.
    J Renin Angiotensin Aldosterone Syst; 2012 Dec 22; 13(4):440-5. PubMed ID: 22392878
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ, Gums JG.
    Ann Pharmacother; 2005 Mar 22; 39(3):470-80. PubMed ID: 15701766
    [Abstract] [Full Text] [Related]

  • 16. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, Lee JK, Lin LY, Lin JW, Hwang JJ, Chiang FT.
    Pharmacogenomics J; 2010 Feb 22; 10(1):46-53. PubMed ID: 19752885
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 22; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant.
    Peters BJ, Maitland-van der Zee AH, Stricker BH, van Wieren-de Wijer DB, de Boer A, Kroon AA, de Leeuw PW, Schiffers P, Janssen RG, van Duijn CM, Klungel OH.
    Pharmacogenet Genomics; 2008 Jul 22; 18(7):631-6. PubMed ID: 18551043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.